Stock Scorecard



Stock Summary for Abbvie Inc (ABBV) - $206.69 as of 8/18/2025 12:00:41 PM EST

Total Score

8 out of 30

Safety Score

63 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ABBV

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ABBV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ABBV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ABBV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ABBV (63 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ABBV

Here is What to Know Beyond Why AbbVie Inc. ( ABBV ) is a Trending Stock 8/18/2025 1:00:00 PM
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today 8/18/2025 9:59:00 AM
This Red-Hot Vanguard ETF Just Hit an All-Time High. Here's Why It's Still Worth Buying in August. 8/16/2025 11:20:00 AM
Marjorie Taylor Greene Keeps Buying UnitedHealth Stock Along With Fellow Investors Buffett And Burry - UnitedHealth Group ( NYSE:UNH ) 8/15/2025 6:09:00 PM
Here's How Much $100 Invested In AbbVie 5 Years Ago Would Be Worth Today - AbbVie ( NYSE:ABBV ) 8/15/2025 2:45:00 PM
3 Dividend Stocks to Double Up On Right Now 8/15/2025 8:53:00 AM
Xilio Revenue Jumps 246 Percent in Q2 8/14/2025 12:03:00 PM
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors 8/13/2025 8:15:00 PM
Henry Fernandez Steps Down from Royalty Pharma's Board of Directors - Royalty Pharma ( NASDAQ:RPRX ) 8/13/2025 8:15:00 PM
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update 8/13/2025 8:15:00 PM

Financial Details for ABBV

Company Overview

Ticker ABBV
Company Name Abbvie Inc
Country USA
Description AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 6/30/2025
Next Earnings Date 10/28/2025

Stock Price History

Last Day Price 206.69
Price 4 Years Ago 117.49
Last Day Price Updated 8/18/2025 12:00:41 PM EST
Last Day Volume 4,430,974
Average Daily Volume 5,328,331
52-Week High 214.80
52-Week Low 159.42
Last Price to 52 Week Low 29.65%

Valuation Measures

Trailing PE 97.00
Industry PE 43.35
Sector PE 59.06
5-Year Average PE 16.77
Free Cash Flow Ratio 56.47
Industry Free Cash Flow Ratio 15.81
Sector Free Cash Flow Ratio 30.26
Current Ratio Most Recent Quarter 0.74
Total Cash Per Share 3.66
Book Value Per Share Most Recent Quarter -0.10
Price to Book Ratio 50.46
Industry Price to Book Ratio 31.11
Sector Price to Book Ratio 26.93
Price to Sales Ratio Twelve Trailing Months 6.20
Industry Price to Sales Ratio Twelve Trailing Months 34.46
Sector Price to Sales Ratio Twelve Trailing Months 15.21
Analyst Buy Ratings 13
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 1,766,560,000
Market Capitalization 365,130,286,400
Institutional Ownership 73.90%

Dividends

Ex-Dividend Date 7/15/2025
Previous Dividend Amount 1.6400
Current Dividend Amount 1.6400
Total Years Dividend Increasing Dividend Contender - Increasing for 12 Years
Trailing Annual Dividend Rate 6.47
Trailing Annual Dividend Yield 3.13%
Forward Annual Dividend Rate 6.56
Forward Annual Dividend Yield 3.17%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 3.59%
5-Year Average Dividend Yield 3.99%
1-Year Dividend Growth Rate Percentage 5.81%
3-Year Dividend Growth Rate Percentage 2.86%
5-Year Dividend Growth Rate Percentage 5.98%
All-Time Dividend Growth Rate Percentage 13.10%
Dividend Payout Ratio 306.64%

Income Statement

Quarterly Earnings Growth YOY -32.40%
Annual Earnings Growth -12.03%
Reported EPS 12 Trailing Months 2.11
Reported EPS Past Year 5.43
Reported EPS Prior Year 10.12
Net Income Twelve Trailing Months 3,769,000,000
Net Income Past Year 4,278,000,000
Net Income Prior Year 4,863,000,000
Quarterly Revenue Growth YOY 6.60%
5-Year Revenue Growth 11.11%
Operating Margin Twelve Trailing Months 37.50%

Balance Sheet

Total Cash Most Recent Quarter 6,467,000,000
Total Cash Past Year 5,524,000,000
Total Cash Prior Year 12,814,000,000
Net Cash Position Most Recent Quarter -56,492,000,000
Net Cash Position Past Year -54,816,000,000
Long Term Debt Past Year 60,340,000,000
Long Term Debt Prior Year 52,194,000,000
Total Debt Most Recent Quarter 62,959,000,000
Equity to Debt Ratio Past Year 0.05
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year 3,325,000,000
Total Stockholder Equity Prior Year 10,360,000,000
Total Stockholder Equity Most Recent Quarter -183,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 18,239,000,000
Free Cash Flow Per Share Twelve Trailing Months 10.32
Free Cash Flow Past Year 17,832,000,000
Free Cash Flow Prior Year 22,062,000,000

Options

Put/Call Ratio 0.31
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 3.20
MACD Signal 2.58
20-Day Bollinger Lower Band 171.12
20-Day Bollinger Middle Band 186.88
20-Day Bollinger Upper Band 202.65
Beta 0.50
RSI 64.53
50-Day SMA 184.84
150-Day SMA 159.10
200-Day SMA 150.29

System

Modified 8/15/2025 4:17:46 PM EST